NEW YORK (GenomeWeb News) — Biobase will integrate its database with GNI’s cellular-imaging software and continue to develop and market the products, GNI said today.
Biobase will develop an interface between its databases, which are designed for gene regulation, signal transduction, and proteomics research, with GNI’s Cell Illustrator 3.0 software, which allows researchers to “create computer images and simulations of complete metabolic and gene regulatory pathways, signal transduction cascades and dynamic interactions.”
The combination “should provide users of the Cell Illustrator with easier access to pathway information and the ability to use the simulation function,” according to GNI.
It will be marketed to pharmaceutical companies, which GNI said will be able to “input their own research data, analyze gene networks with their own personal computers and carry out model analysis based on pathways.”
Pharmaceutical customers will be able to share research content and perform final experiments based on results from simulated tests, GNI said.
Biobase is headquartered in Germany. GNI is based in Tokyo.